Global Colchicine Market Insights, Forecast to 2025

2 Global Colchicine Quarterly Market Size Analysis

• 2.1 Colchicine Business Impact Assessment - COVID-19
  • 2.1.1 Global Colchicine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Colchicine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Colchicine Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Colchicine Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Colchicine Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Colchicine Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Colchicine Market
• 3.5 Key Manufacturers Colchicine Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Colchicine Segments, By Type

• 4.1 Introduction
  • 1.4.1 Tablet
  • 1.4.2 Oral Solution
• 4.2 By Type, Global Colchicine Market Size, 2019-2021
  • 4.2.1 By Type, Global Colchicine Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Colchicine Price, 2020-2021

5 Impact of Covid-19 on Colchicine Segments, By Application

• 5.1 Overview
  • 5.5.1 Acute Gout
  • 5.5.2 Chronic Gout
  • 5.5.3 Other Conditions
• 5.2 By Application, Global Colchicine Market Size, 2019-2021
  • 5.2.1 By Application, Global Colchicine Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Colchicine Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Takeda Pharmaceuticals
  • 7.1.1 Takeda Pharmaceuticals Business Overview
  • 7.1.2 Takeda Pharmaceuticals Colchicine Quarterly Production and Revenue, 2020
  • 7.1.3 Takeda Pharmaceuticals Colchicine Product Introduction
  • 7.1.4 Takeda Pharmaceuticals Response to COVID-19 and Related Developments
• 7.2 Hikma
  • 7.2.1 Hikma Business Overview
  • 7.2.2 Hikma Colchicine Quarterly Production and Revenue, 2020
  • 7.2.3 Hikma Colchicine Product Introduction
  • 7.2.4 Hikma Response to COVID-19 and Related Developments
• 7.3 Cipla
  • 7.3.1 Cipla Business Overview
  • 7.3.2 Cipla Colchicine Quarterly Production and Revenue, 2020
  • 7.3.3 Cipla Colchicine Product Introduction
  • 7.3.4 Cipla Response to COVID-19 and Related Developments
• 7.4 Wockhardt
  • 7.4.1 Wockhardt Business Overview
  • 7.4.2 Wockhardt Colchicine Quarterly Production and Revenue, 2020
  • 7.4.3 Wockhardt Colchicine Product Introduction
  • 7.4.4 Wockhardt Response to COVID-19 and Related Developments
• 7.5 West-Ward
  • 7.5.1 West-Ward Business Overview
  • 7.5.2 West-Ward Colchicine Quarterly Production and Revenue, 2020
  • 7.5.3 West-Ward Colchicine Product Introduction
  • 7.5.4 West-Ward Response to COVID-19 and Related Developments
• 7.6 Excellium Pharmaceutical
  • 7.6.1 Excellium Pharmaceutical Business Overview
  • 7.6.2 Excellium Pharmaceutical Colchicine Quarterly Production and Revenue, 2020
  • 7.6.3 Excellium Pharmaceutical Colchicine Product Introduction
  • 7.6.4 Excellium Pharmaceutical Response to COVID-19 and Related Developments
• 7.7 Rhea Pharmaceutical
  • 7.7.1 Rhea Pharmaceutical Business Overview
  • 7.7.2 Rhea Pharmaceutical Colchicine Quarterly Production and Revenue, 2020
  • 7.7.3 Rhea Pharmaceutical Colchicine Product Introduction
  • 7.7.4 Rhea Pharmaceutical Response to COVID-19 and Related Developments
• 7.8 Medinova
  • 7.8.1 Medinova Business Overview
  • 7.8.2 Medinova Colchicine Quarterly Production and Revenue, 2020
  • 7.8.3 Medinova Colchicine Product Introduction
  • 7.8.4 Medinova Response to COVID-19 and Related Developments
• 7.9 Odan Laboratories
  • 7.9.1 Odan Laboratories Business Overview
  • 7.9.2 Odan Laboratories Colchicine Quarterly Production and Revenue, 2020
  • 7.9.3 Odan Laboratories Colchicine Product Introduction
  • 7.9.4 Odan Laboratories Response to COVID-19 and Related Developments
• 7.10 Prasco
  • 7.10.1 Prasco Business Overview
  • 7.10.2 Prasco Colchicine Quarterly Production and Revenue, 2020
  • 7.10.3 Prasco Colchicine Product Introduction
  • 7.10.4 Prasco Response to COVID-19 and Related Developments
• 7.11 Kunming Pharmaceutical
  • 7.11.1 Kunming Pharmaceutical Business Overview
  • 7.11.2 Kunming Pharmaceutical Colchicine Quarterly Production and Revenue, 2020
  • 7.11.3 Kunming Pharmaceutical Colchicine Product Introduction
  • 7.11.4 Kunming Pharmaceutical Response to COVID-19 and Related Developments
• 7.12 Yunnan Plant Medicine
  • 7.12.1 Yunnan Plant Medicine Business Overview
  • 7.12.2 Yunnan Plant Medicine Colchicine Quarterly Production and Revenue, 2020
  • 7.12.3 Yunnan Plant Medicine Colchicine Product Introduction
  • 7.12.4 Yunnan Plant Medicine Response to COVID-19 and Related Developments
• 7.13 Xishuangbanna Pharmaceutical
  • 7.13.1 Xishuangbanna Pharmaceutical Business Overview
  • 7.13.2 Xishuangbanna Pharmaceutical Colchicine Quarterly Production and Revenue, 2020
  • 7.13.3 Xishuangbanna Pharmaceutical Colchicine Product Introduction
  • 7.13.4 Xishuangbanna Pharmaceutical Response to COVID-19 and Related Developments
• 7.14 Guangdong Pedi
  • 7.14.1 Guangdong Pedi Business Overview
  • 7.14.2 Guangdong Pedi Colchicine Quarterly Production and Revenue, 2020
  • 7.14.3 Guangdong Pedi Colchicine Product Introduction
  • 7.14.4 Guangdong Pedi Response to COVID-19 and Related Developments
• 7.15 Yunnan Shan State
  • 7.15.1 Yunnan Shan State Business Overview
  • 7.15.2 Yunnan Shan State Colchicine Quarterly Production and Revenue, 2020
  • 7.15.3 Yunnan Shan State Colchicine Product Introduction
  • 7.15.4 Yunnan Shan State Response to COVID-19 and Related Developments
• 7.16 Tonghua Limin
  • 7.16.1 Tonghua Limin Business Overview
  • 7.16.2 Tonghua Limin Colchicine Quarterly Production and Revenue, 2020
  • 7.16.3 Tonghua Limin Colchicine Product Introduction
  • 7.16.4 Tonghua Limin Response to COVID-19 and Related Developments
• 7.17 Beijing Jialin Pharmaceutical
  • 7.17.1 Beijing Jialin Pharmaceutical Business Overview
  • 7.17.2 Beijing Jialin Pharmaceutical Colchicine Quarterly Production and Revenue, 2020
  • 7.17.3 Beijing Jialin Pharmaceutical Colchicine Product Introduction
  • 7.17.4 Beijing Jialin Pharmaceutical Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Colchicine Supply Chain Analysis
  • 8.1.1 Colchicine Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Colchicine Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Colchicine Distribution Channels
  • 8.2.2 Covid-19 Impact on Colchicine Distribution Channels
  • 8.2.3 Colchicine Distributors
• 8.3 Colchicine Customers

9 Key Findings

10 Appendix

• 10.1 About Us